课题基金 / 基金详情

A Double-Blind Randomized Controlled Trial Evaluating the Efficacy of Repetitive Transcranial Magnetic Stimulation as Treatment for Major Depressive Disorder in Transition-Age Youth with Autism Spectrum Disorder

A Double-Blind Randomized Controlled Trial Evaluating the Efficacy of Repetitive Transcranial Magnetic Stimulation as Treatment for Major Depressive Disorder in Transition-Age Youth with Autism Spectrum Disorder
一项双盲随机对照试验，评估重复经颅磁刺激治疗患有自闭症谱系障碍的过渡年龄青少年重度抑郁症的疗效
批准号：
435867
负责人：
Ameis Stephanie H
金额：
$46.53万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2020
资助国家：
加拿大
项目状态：
未结题
起止时间：
2020-10-01 至 2025-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=435867&lang=en
关键词：
Autism Depression Transition Age Youth

项目摘要

项目成果

Ameis Stephanie H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Depression in autism contributes to disability, social impairment, and is a risk factor for suicide. However, there are no approved treatments. Repetitive transcranial magnetic stimulation(rTMS) is approved for the treatment of depression by Health Canada
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 2
  • 批准号：
    471128
  • 项目类别：
  • 资助金额：
    $43.71万
  • 财政年份：
    2022
  • 负责人：
    Ameis Stephanie H
  • 依托单位：
    University of Toronto
Synaptic density as a marker of impairment in autism spectrum disorder
海外基金